Systematic Review: Diagnostic Accuracy of Clinical Decision Rules for Venous Thromboembolism in Elderly Publication Systematic Review: Diagnostic Accuracy of Clinical Decision Rules for Venous Thromboembolism in Elderly Physicians committed to the care of elderly patients are challenged with the diagnosis of venous…Certara2011年4月1日
Sources of Interindividual Variability in IVIVE of Clearance: An Investigation into the Prediction of Benzodiazepine Clearance Using a Mechanistic Population-based Pharmacokinetic Model Publication Sources of Interindividual Variability in IVIVE of Clearance: An Investigation into the Prediction of Benzodiazepine Clearance Using a Mechanistic Population-based Pharmacokinetic Model Prediction of metabolic clearance in extreme individuals rather than the 'average human' is becoming an…Certara2011年3月24日
Is a Monte Carlo Simulation an Exotic Drink? 技術情報 Is a Monte Carlo Simulation an Exotic Drink? The term “Monte Carlo simulation” is often used in the modeling and simulation literature with…Certara2011年3月21日
What is the Difference Between Individual and Population PK? 技術情報 What is the Difference Between Individual and Population PK? Pharmacokinetic analysis is often broken into two areas … “PK” and “population PK”. Sometimes the…Certara2011年3月14日
Utility of Intersystem Extrapolation Factors in Early Reaction Phenotyping and the Quantitative Extrapolation of Human Liver Microsomal Intrinsic Clearance Using Recombinant Cytochromes P450 Publication Utility of Intersystem Extrapolation Factors in Early Reaction Phenotyping and the Quantitative Extrapolation of Human Liver Microsomal Intrinsic Clearance Using Recombinant Cytochromes P450 Reaction phenotyping using recombinant human cytochromes P450 (P450) has great utility in early discovery. However,…Certara2011年3月1日
Casopitant: In Vitro Data and Simcyp Simulation to Predict In Vivo Metabolic Interactions Involving Cytochrome P450 3A4 Publication Casopitant: In Vitro Data and Simcyp Simulation to Predict In Vivo Metabolic Interactions Involving Cytochrome P450 3A4 has previously been shown to be a potent and selective antagonist of the human neurokinin-1…Certara2011年3月1日
Modeling and Predicting Drug Pharmacokinetics in Patients with Renal Impairment Publication Modeling and Predicting Drug Pharmacokinetics in Patients with Renal Impairment Current guidance issued by the US FDA to assess the impact of renal impairment on…Certara2011年3月1日
Resurgence in the Use of Physiologically-based Pharmacokinetic Models in Pediatric Clinical Pharmacology: Parallel Shift in Incorporating the Knowledge of Biological Elements and Increased Applicability to Drug Development and Clinical Practice Publication Resurgence in the Use of Physiologically-based Pharmacokinetic Models in Pediatric Clinical Pharmacology: Parallel Shift in Incorporating the Knowledge of Biological Elements and Increased Applicability to Drug Development and Clinical Practice This study had two primary aims: (i) To describe an example of the development work…Certara2011年3月1日
Why are PK Parameters Lognormally Distributed? 技術情報 Why are PK Parameters Lognormally Distributed? The statistical analysis of pharmacokinetic parameters is often overlooked and not always well understood. The…Certara2011年2月10日
What are Direct and Indirect Pharmacodynamic Models? 技術情報 What are Direct and Indirect Pharmacodynamic Models? When constructing pharmacodynamic (PD) models, you will often encounter the adjectives “direct” and “indirect” describing…Certara2011年2月8日